Showing 261-270 of 2253 results for "".
Practical Considerations for Family Planning in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/practical-considerations-for-family-planning-in-multiple-sclerosis/32086/Family planning is an integral part of comprehensive multiple sclerosis care for women of childbearing age.Alzheimer Disease Support Groups
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/alzheimer-disease-support-groups/31914/A care partner plea for physicians to inform patients and care partners about Alzheimer disease support groups.Poststroke Recrudescence:
Current Evidence and Considerations for Clinical Practicehttps://practicalneurology.com/diseases-diagnoses/stroke/poststroke-recrudescencebrcurrent-evidence-and-considerations-for-clinical-practice/32073/Despite the high prevalence of recrudescence after stroke and the importance of correct identification of recurrent cerebral ischemia, poststroke recrudescence is poorly understood.Digital Cognitive Assessments for Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/digital-cognitive-assessments-for-dementia/31728/Digital assessments may enhance the efficiency of evaluations in neurology and other clinics.The Minimal Clinically Important Difference and Its Use in Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/the-minimal-clinically-important-difference-and-its-use-in-neuromuscular-disorders/35532/The minimal clinically important difference facilitates the determination of clinically important and relevant outcome measures in clinical trials and clinical applications and is a promising alternative to statistical significance.Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: Current Landscape and Potential Utility in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/blood-and-cerebrospinal-fluid-biomarkers-in-amyotrophic-lateral-sclerosis-current-landscape-and-potential-utility-in-clinical-practice/35542/Amyotrophic lateral sclerosis biomarkers are increasingly shaping the development of new treatments.Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/diseases-diagnoses/headache-pain/chronic-inflammatory-demyelinating-polyneuropathy/31813/Updates in diagnosis and management.Fatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fatigue-in-multiple-sclerosis-a-comprehensive-approach-to-evaluation-and-management/32087/Management of fatigue in multiple sclerosis requires a holistic approach tailored to the individual.Headache Horizons: Emerging Use of Ketamine for the Treatment of Migraine and Other Headache Disorders
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-emerging-use-of-ketamine-for-the-treatment-of-migraine-and-other-headache-disorders/32171/An increasing body of research is proving ketamine to be an effective treatment option for migraine and other headache disorders.Small Fiber Neuropathy
https://practicalneurology.com/diseases-diagnoses/headache-pain/small-fiber-neuropathy/31811/Small fiber neuropathy has a benign course but can affect quality of life; individualize treatment to control underlying causes and alleviate pain.